معرفی
Dr. James Randall serves as an Assistant Professor of Radiation Oncology at Washington University School of Medicine, where he is affiliated with the Division of Clinical Research and Siteman Cancer Center. His clinical practice focuses on treating genitourinary cancers and central nervous system malignancies with advanced radiotherapy techniques.
Dr. Randall's research interests span oncologic imaging, clinical outcomes, and the application of machine learning in radiation therapy. His work particularly emphasizes adaptive radiotherapy, stereotactic radiotherapy, and MR-linac technology, with significant contributions to prostate cancer, glioblastoma, and lung cancer treatment. His research portfolio demonstrates a strong focus on integrating imaging technology with precision radiation delivery to improve cancer treatment outcomes.
Analysis of Dr. Randall's publication record from 2017-2024 reveals a clear trajectory toward increasingly sophisticated applications of imaging and artificial intelligence in radiation oncology. His work spans multiple cancer types but maintains consistent themes of technological innovation in treatment delivery, particularly through MR-guided radiotherapy systems and machine learning applications for personalized treatment planning. The interdisciplinary nature of his research bridges medical physics, oncology, and computer science to address clinical challenges in cancer treatment.
Dr. Randall completed his medical education at The University of Texas Medical Branch (2019), followed by an Internal Medicine internship at Ascension St. Francis Hospital (2020), and a Radiation Oncology residency at Northwestern University Feinberg School of Medicine (2023). His undergraduate degree in Microbiology was earned at The University of Texas at Austin (2015).
As a dedicated educator, Dr. Randall serves as Medical Student Director and has been involved in developing curricula for medical students and residents. His clinical expertise encompasses genitourinary cancers (prostate, bladder, testicular, renal), central nervous system cancers (glioma, meningioma, ependymoma), metastatic cancers, stereotactic radiotherapy, and adaptive radiotherapy techniques.
